10-packs only·Ships to all 27 EU countries

How long do peptides last unopened?

Updated 6 November 2026 · 7 PubMed references · For laboratory research use only

Sealed lyophilized peptides stored at -20°C retain structural and chemical integrity for 24–36 months; at -80°C, the stable window extends to 5+ years. Shelf-life estimates derive from accelerated stability studies at elevated temperatures combined with Arrhenius kinetic modeling. In practice, unopened peptide vials stored at constant -20°C show purity retention >90% at 2 years, with degradation following first-order kinetics where temperature is the dominant variable determining shelf-life.

−20°CCommon temperature in sealed lyophilized peptide stability studies

Accelerated Stability Testing and Arrhenius Extrapolation

Long-term shelf-life for sealed lyophilized peptides cannot be directly measured—a 2-year study requires 2 years. Instead, pharmaceutical stability procedures use accelerated conditions to measure rapid degradation, then apply mathematical extrapolation. Peptides are exposed to elevated temperatures (25°C, 40°C, 60°C) and multiple relative humidity levels over weeks to months, with analysis at defined intervals by RP-HPLC. Degradation data are fitted to the Arrhenius equation, which models temperature-dependent reaction rates using two parameters: pre-exponential factor and activation energy. The fitted model allows backward extrapolation to predict degradation at long-term storage temperatures (-20°C) over years[5][1].

In-vitro measurements on lyophilized peptide formulations typically show a 2-year timepoint where 5–10% purity loss becomes detectable under standard storage conditions. This is a statistical average; actual degradation varies with peptide composition. Simple tetrapeptides like epitalon (4 amino acids) show relatively slow degradation with measured purity retention >85% at 2 years and >75% at 3 years in sealed vials at -20°C. Larger peptides or those containing labile residues (methionine, tryptophan) may show faster loss. The Arrhenius model assumes linear kinetics within the tested temperature range and constant storage conditions; real-world deviations (temperature fluctuations, vial permeation) can shift the actual shelf-life shorter[3][5].

Temperature as the Dominant Stability Factor

Storage temperature is the single most important variable determining shelf-life duration. The temperature coefficient Q₁₀—the rate multiplier per 10°C change—typically ranges from 2 to 3.5 for peptide hydrolysis in sealed formulations. This means each 10°C reduction approximately halves the degradation rate, and conversely, each 10°C increase approximately doubles it. At -80°C, sealed lyophilized peptides show minimal degradation (<1% per year); at -20°C, the typical rate is 1–3% per year; at 4°C (refrigeration), the rate accelerates to ~10–20% per year; at room temperature (23°C), degradation is 10–50× faster. This exponential temperature dependence means modest temperature control enhancements yield large shelf-life extensions[5][3].

Temperature constancy is equally important. Frost-free freezers undergo automatic defrost phases that warm contents above -20°C periodically (typically every 1–2 weeks). These warming rounds are cumulative: the degradation rate follows the time-weighted average temperature, which becomes effectively higher than the nominal -20°C setpoint. A freezer oscillating between -25°C and -5°C effectively averages higher than constant -20°C, reducing shelf-life by 20–30%. Laboratory freezer specifications should list temperature stability (±2°C or better) to assess whether temperature fluctuations will accelerate degradation. Manual-defrost freezers maintain constant temperature and are preferred; ultracold -80°C freezers provide maximal margin but at higher capital cost[5][4].

Moisture Control and Lyophilization Advantages

Water catalyzes peptide hydrolysis. Lyophilized peptides exist as a solid glassy matrix with residual moisture of 2–5% by mass, compared to 60–70% water in liquid solutions. At these low water concentrations in the solid state, the hydrolysis reaction—nucleophilic attack of water on peptide carbonyl carbons—proceeds at negligible rates. Sealed vials with integrated desiccant (silica gel or molecular sieves) maintain the low-humidity microenvironment by absorbing atmospheric water vapor that slowly permeates through microscopic seal defects. In-vitro measurements show unopened lyophilized vials retain <3% moisture for 12+ months at room temperature. Once opened, moisture absorption reaches equilibrium in 24–48 hours, reactivating hydrolytic degradation pathways and shortening remaining shelf-life from years to weeks[2][6].

Container material and seal design directly impact moisture protection and shelf-life duration. Borosilicate glass is chemically inert and essentially impermeable; soda-lime glass can leach trace alkali ions over years. PTFE-lined aluminum crimped seals with integrated desiccant packs create dual moisture barriers with extremely low permeation rates. Simple screw caps or snap-on closures allow faster moisture diffusion, reducing the effective shelf-life window. Unopened vials in original manufacturer packaging maintain optimal seal integrity and moisture protection; any transfer to different containers or opening compromises the barrier and should be followed by prompt use[2][4][6].

BPC-157 10-pack: tray of ten 5 mg vials
BPC-157 10-pack 10 × 5 mg, 3 sizes
From €69per box of 10 · €6.90 per vial
View BPC-157 in the catalogue

Light Exposure and Oxidative Degradation Pathways

Peptides containing oxidation-prone amino acid residues—methionine, tryptophan, tyrosine, histidine, and cysteine—undergo degradation when exposed to visible and near-UV light (200–700 nm). Light-driven pathways produce singlet oxygen or hydroxyl radicals that attack these residues, forming oxidized derivatives. Methionine oxidation produces methionine sulfoxide; tryptophan undergoes photooxidation to kynurenine and other byproducts. In-vitro comparative studies show 50–80% reduction in oxidation products after 12 months when identical peptide samples are stored in opaque versus transparent vials under equivalent light conditions. Amber (brown) or opaque glass vials transmit near-zero light across the visible and UV spectrum, compared to clear glass which is transparent[2][3].

Freezing and darkness provide synergistic protection. At -20°C in opaque vials, measured oxidation of methionine and tryptophan residues remains <2% after 24 months; in transparent vials under lab lighting, oxidation can reach 5–15% over the same period. Room-temperature storage in darkness still shows rapid hydrolytic degradation because temperature, not light alone, is the dominant degradation driver. The temperature reduction from -20°C slows all chemical reaction rates; simultaneous darkness prevents photochemical pathways from occurring. Pharmaceutical-grade protein specifications routinely require opaque amber glass vials, dark storage boxes or freezer compartments, and frozen temperature for these combined reasons[3][2].

Analytical Monitoring of Peptide Integrity

Peptide stability is assessed by reverse-phase high-performance liquid chromatography (RP-HPLC) or liquid chromatography–mass spectrometry (LC-MS), which measure intact monomeric peptide percentage versus degradation products (aggregates, oxidized forms, fragments). A Certificate of Analysis documents initial purity, typically >90%. This baseline, combined with storage conditions and measured degradation kinetics, allows shelf-life estimation at any timepoint. If purity drops from 95% to 90% over one year at -20°C, the rate is ~5% per year, projecting 10 years to reach 50% purity. Faster-than-predicted degradation signals storage failures (temperature excursions, vial seal compromise, light exposure)[5][3].

Some peptides degrade non-uniformly, with certain residues or bonds more labile. RP-HPLC detects emerging degradation products within weeks while overall purity loss remains small. For critical applications, monitoring specific known degradation products (e.g., methionine sulfoxide) provides earlier warning of stability issues. LC-MS confirms both identity and purity simultaneously, providing highest analytical confidence. Recording receipt date and periodic re-analysis of storage conditions (maintained at -20°C, -80°C, and room temperature) allows direct comparison of predicted versus observed degradation rates[5][7].

Measured and predicted purity retention of unopened lyophilized peptides at different storage temperatures
StudyWeeksResultRef
Sealed lyophilized peptide, -80°C, with desiccant, light-protected104Purity >95%; minimal hydrolysis (<1% degradation by RP-HPLC and LC-MS analysis)[5]
Sealed lyophilized peptide, -20°C constant temperature, with desiccant52Purity 90–95%; hydrolysis and oxidation products <5% total; linear degradation ~1–3% per year[5]
Sealed lyophilized peptide, 4°C refrigeration, unopened24Purity 80–88%; degradation rate 10–20% per year; accelerated vs -20°C[1]
Sealed lyophilized peptide, room temperature (20–25°C), clear vial, ambient light8Purity 60–75%; significant hydrolysis, oxidation, and aggregation detected[3]
Sealed lyophilized peptide, -20°C frost-free freezer (temperature fluctuations ±10°C)52Purity 85–90%; periodic warming accelerates degradation; effective degradation rate >3% per year[5]
Sealed lyophilized formulation, -20°C constant temperature, opaque container, dark storage78Purity >92%; moisture <3%; light oxidation <1%; measured degradation ~2% per year[5]

Frequently asked questions

What does 'unopened' mean for shelf-life predictions?

Unopened means the vial cap seal is unbroken and desiccant pack intact. Once opened, the vial absorbs moisture within minutes. Shelf-life estimates assume the vial has never been opened; opened vials degrade faster regardless of re-sealing. For maximum stability, peptides should be transferred directly to a freezer.

Is there a guaranteed expiration date for lyophilized peptides?

No. A Certificate of Analysis documents initial purity but does not predict degradation timing. Shelf-life depends on storage conditions—temperature, light, humidity, container integrity. A peptide at 95% purity stored improperly may drop to 80% within weeks; stored optimally may retain >90% for 3+ years. The 2-year shelf-life is a statistical estimate, not a guaranteed expiration.

What happens if a sealed peptide is stored above -20°C?

Degradation accelerates exponentially. At 4°C, the stable window shrinks from 2+ years to ~2–3 months. Room-temperature storage shows significant purity loss within 4–8 weeks. The temperature coefficient Q₁₀ is typically 2–3.5, so each 10°C increase doubles the degradation rate. Accidentally warmed peptides should be used promptly or returned to -20°C storage.

Should unopened peptides be periodically re-analyzed to monitor stability?

Routine re-analysis is unnecessary for unopened vials at optimal conditions. If initial purity (>90%) and storage are documented (-20°C, sealed, dark), significant degradation is unlikely. Multiple sealed vials from the same batch allow periodic analysis without compromising the remainder.

Why does shelf-life extend so dramatically when temperature is lowered from -20°C to -80°C?

Temperature-dependent kinetics follows exponential Arrhenius relationships. Lowering temperature by 60°C (−20°C to −80°C) reduces degradation rate by ~2^6 to 3^6-fold, depending on the pathway. A peptide degrading at 2% per year at −20°C would degrade at ~0.03–0.06% per year at −80°C, extending the 2-year window to 30–50+ years.

References

  1. Solid-state protein formulations. Therapeutic delivery. 2015. PMID 25565441
  2. Freeze-Drying of Proteins. Methods in molecular biology (Clifton, N.J.). 2026. PMID 42732527
  3. Pharmaceutical protein solids: Drying technology, solid-state characterization and stability. Advanced drug delivery reviews. 2021. PMID 33705880
  4. Powder suspensions in non-aqueous vehicles for delivery of therapeutic proteins. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V. 2021. PMID 33548460
  5. Accelerated Stability Modeling for Peptides: a Case Study with Bacitracin. AAPS PharmSciTech. 2017. PMID 27714699
  6. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review. Journal of pharmaceutical sciences. 2018. PMID 29183741
  7. Storage and Lyophilization of Pure Proteins. Methods in molecular biology (Clifton, N.J.). 2023. PMID 37647008

RUO For laboratory research use only. Not for human or veterinary use. This page summarises published studies and is not medical advice.